海特生物：拟发行H股股票并在香港联合交易所有限公司上市

Core Viewpoint - The company plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange to enhance its competitiveness and international brand image while diversifying its financing channels [1] Group 1 - The company will hold the seventh meeting of the ninth board of directors on January 20, 2026, to review proposals related to the issuance of H-shares [1] - The proposals include the issuance of overseas listed foreign shares (H-shares) and the plan for listing on the main board of the Hong Kong Stock Exchange [1] - The initiative aims to better utilize international capital markets [1]